Rarely acquired type II-A CRISPR-Cas spacers mediate anti-viral immunity through the targeting of a non-canonical PAM sequence
Next generation sequences from experiments pertaining to the functioning of the Streptococcus pyogenes type II-A CRISPR-Cas system, expressed in Staphylococcus aureus cells.